biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Some are completely missing point

<< Previous

Bullboard Posts

Next >>

Comment by regardlesson Jan 22, 2021 3:55pm

156 Views

Post# 32361871

RE:RE:Some are completely missing point

Having seen what we just saw you have to belive that any solid news or a partnership can make this blow up 2-300% because I doubt volume will be a messily 600k on those days

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario